Khiron (KHRN.V) has been backed by the Colombian Association of Gerontology and Geriatrics (CAGG), bolstering the company’s reach with the key demographic of Latin American seniors. A May 2019…
KHRN.V
Khiron Life Sciences (KHRN.V) announced Thursday that it is finally ready to commercialize its massive Colombian grow site by the end of next month. Beyond Colombia, Khiron recently unveiled…
Khiron Life Sciences (KHRN.V) has added two former Canopy Growth (WEED.T) executives to spearhead European operations in a move designed to grab as much market share across the pond as possible. Prohibition…
Khiron Life Sciences (KHRN.V) is using its industry connections to take on the multi-billion-dollar U.S. skincare market. You see, skincare is just one of the many industry verticals being…
There is a dearth of cannabis-related clinical studies, and Khiron Life Sciences (KHRN.V) is putting in the work to change that. Today, the company has begun its pre-clinical medical cannabis studies…
Khiron Life Sciences (KHRN.V) announced today that their brand of cosmeceuticals will be on display in Cosmoprof North America, a B2B beauty event in North America, on July 28…
Khiron Life Sciences (KHRN.C) is the only Colombian cannabis company generating revenue from legal production. We checked. After the acquisition of ILANS and the launch of the cosmeceutical brand,…
Chemesis International (CSI.C) subsidiary, Natural Ventures, has signed a three year, USD$6M minimum purchase agreement with PR ONE, a medical cannabis company based in Puerto Rico. Over the deal’s three-year…
Your weed bet is (probably) down, and no, this isn’t a repost. If you’re a diversified investor, you’re laughing. The S&P/TSX Composite Index is up a tad since January…
Navigating the regulatory maze of Colombian cannabis to get products to market is not a task for amateurs. There’s some logic behind wrapping up the production, distribution and sale…